Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133322) titled 'A clinical study comparing 730-nm and 1064-nm picosecond lasers for Hori's nevus' on Sept. 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Henan Provincial People's Hospita,medical
Condition:
Acquired dermal melanocytosis
Intervention:
730-nm picosecond laser group:730-nm picosecond laser treatment
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: 730-nm picosecond laser group:60;1064-nm picosecond laser group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=343932
P...